These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 32382832)

  • 1. Magnetic Nanoparticles as MRI Contrast Agents.
    Avasthi A; Caro C; Pozo-Torres E; Leal MP; García-Martín ML
    Top Curr Chem (Cham); 2020 May; 378(3):40. PubMed ID: 32382832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution and Tumors MRI Contrast Enhancement of Magnetic Nanocubes, Nanoclusters, and Nanorods in Multiple Mice Models.
    Naumenko V; Garanina A; Nikitin A; Vodopyanov S; Vorobyeva N; Tsareva Y; Kunin M; Ilyasov A; Semkina A; Chekhonin V; Abakumov M; Majouga A
    Contrast Media Mol Imaging; 2018; 2018():8264208. PubMed ID: 30344459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Insight about Biocompatibility and Biodegradability of Iron Oxide Magnetic Nanoparticles: Stereological and In Vivo MRI Monitor.
    Nosrati H; Salehiabar M; Fridoni M; Abdollahifar MA; Kheiri Manjili H; Davaran S; Danafar H
    Sci Rep; 2019 May; 9(1):7173. PubMed ID: 31073222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocompatible Peptide-Coated Ultrasmall Superparamagnetic Iron Oxide Nanoparticles for In Vivo Contrast-Enhanced Magnetic Resonance Imaging.
    Chee HL; Gan CRR; Ng M; Low L; Fernig DG; Bhakoo KK; Paramelle D
    ACS Nano; 2018 Jul; 12(7):6480-6491. PubMed ID: 29979569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tailor-made PEG coated iron oxide nanoparticles as contrast agents for long lasting magnetic resonance molecular imaging of solid cancers.
    Lazaro-Carrillo A; Filice M; Guillén MJ; Amaro R; Viñambres M; Tabero A; Paredes KO; Villanueva A; Calvo P; Del Puerto Morales M; Marciello M
    Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110262. PubMed ID: 31761230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design considerations for the synthesis of polymer coated iron oxide nanoparticles for stem cell labelling and tracking using MRI.
    Barrow M; Taylor A; Murray P; Rosseinsky MJ; Adams DJ
    Chem Soc Rev; 2015 Oct; 44(19):6733-48. PubMed ID: 26169237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theranostic nanoparticles based on magnetic nanoparticles: design, preparation, characterization, and evaluation as novel anticancer drug carrier and MRI contrast agent.
    Nosrati H; Salehiabar M; Kheiri Manjili H; Davaran S; Danafar H
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1668-1678. PubMed ID: 29848101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron oxide nanoparticles - In vivo/in vitro biomedical applications and in silico studies.
    Nedyalkova M; Donkova B; Romanova J; Tzvetkov G; Madurga S; Simeonov V
    Adv Colloid Interface Sci; 2017 Nov; 249():192-212. PubMed ID: 28499604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of iron oxide-based nanoparticles for MRI and magnetic hyperthermia.
    Blanco-Andujar C; Walter A; Cotin G; Bordeianu C; Mertz D; Felder-Flesch D; Begin-Colin S
    Nanomedicine (Lond); 2016 Jul; 11(14):1889-910. PubMed ID: 27389703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody.
    Ding N; Sano K; Kanazaki K; Ohashi M; Deguchi J; Kanada Y; Ono M; Saji H
    Mol Imaging Biol; 2016 Dec; 18(6):870-876. PubMed ID: 27351762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gold-coated magnetic nanoparticle as a nanotheranostic agent for magnetic resonance imaging and photothermal therapy of cancer.
    Eyvazzadeh N; Shakeri-Zadeh A; Fekrazad R; Amini E; Ghaznavi H; Kamran Kamrava S
    Lasers Med Sci; 2017 Sep; 32(7):1469-1477. PubMed ID: 28674789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparative Study of Receptor-Targeted Magnetosome and HSA-Coated Iron Oxide Nanoparticles as MRI Contrast-Enhancing Agent in Animal Cancer Model.
    Erdal E; Demirbilek M; Yeh Y; Akbal Ö; Ruff L; Bozkurt D; Cabuk A; Senel Y; Gumuskaya B; Algın O; Colak S; Esener S; Denkbas EB
    Appl Biochem Biotechnol; 2018 May; 185(1):91-113. PubMed ID: 29082480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Block copolymer cross-linked nanoassemblies improve particle stability and biocompatibility of superparamagnetic iron oxide nanoparticles.
    Dan M; Scott DF; Hardy PA; Wydra RJ; Hilt JZ; Yokel RA; Bae Y
    Pharm Res; 2013 Feb; 30(2):552-61. PubMed ID: 23080062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendrimer functionalized magnetic nanoparticles as a promising platform for localized hyperthermia and magnetic resonance imaging diagnosis.
    Esmaeili E; Khalili M; Sohi AN; Hosseinzadeh S; Taheri B; Soleimani M
    J Cell Physiol; 2019 Aug; 234(8):12615-12624. PubMed ID: 30536886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paramagnetic and Superparamagnetic Inorganic Nanoparticles for T1-Weighted Magnetic Resonance Imaging.
    Zeng L; Wu D; Zou R; Chen T; Zhang J; Wu A
    Curr Med Chem; 2018; 25(25):2970-2986. PubMed ID: 28292235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast Agents Based on Iron Oxide Nanoparticles for Clinical Magnetic Resonance Imaging.
    Abakumov MA; Ternovoi SK; Mazhuga AG; Chekhonin VP; Demikhov EI; Pistrak AG; Konstantinov MV; Dmitriev DM; Myshkinis BY
    Bull Exp Biol Med; 2019 Jun; 167(2):272-274. PubMed ID: 31243671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR4-targeted and MMP-responsive iron oxide nanoparticles for enhanced magnetic resonance imaging.
    Gallo J; Kamaly N; Lavdas I; Stevens E; Nguyen QD; Wylezinska-Arridge M; Aboagye EO; Long NJ
    Angew Chem Int Ed Engl; 2014 Sep; 53(36):9550-4. PubMed ID: 25045009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.
    Unterweger H; Janko C; Schwarz M; Dézsi L; Urbanics R; Matuszak J; Őrfi E; Fülöp T; Bäuerle T; Szebeni J; Journé C; Boccaccini AR; Alexiou C; Lyer S; Cicha I
    Int J Nanomedicine; 2017; 12():5223-5238. PubMed ID: 28769560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabeled ultra-small Fe
    Sun H; Zhang B; Jiang X; Liu H; Deng S; Li Z; Shi H
    Nanomedicine (Lond); 2019 Jan; 14(1):5-17. PubMed ID: 30451578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular imaging of activated platelets via antibody-targeted ultra-small iron oxide nanoparticles displaying unique dual MRI contrast.
    Ta HT; Li Z; Hagemeyer CE; Cowin G; Zhang S; Palasubramaniam J; Alt K; Wang X; Peter K; Whittaker AK
    Biomaterials; 2017 Jul; 134():31-42. PubMed ID: 28453956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.